The death receptor CD95 (Fas, Apo-1) expression and Annexin-V binding of phosphatidylserine in lymphocytes in bronchial asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 757s Year: 2006
Enhanced expression of Fas ligand (FasL) in fibrotic interstitial lung diseases (ILDs). The possible role of membrane-bound FasL form Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011
T cell chemokine receptor expression in COPD Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012
Fas Ligand (FasL) expressed on alveolar lymphocytes (AL) plays role in progression of interstitial lung diseases (ILD) but not in local induction of immune cells apoptosis Source: Eur Respir J 2005; 26: Suppl. 49, 542s Year: 2005
Polarization of the chemokine receptor CXCR6 according to activation status of human lung T cells Source: Eur Respir J 2003; 22: Suppl. 45, 571s Year: 2003
Deletion in macrophage chemokine receptor gene (CCR5) in children with bronchial asthma (BA) Source: Eur Respir J 2001; 18: Suppl. 33, 450s Year: 2001
T cell recruitment to the human asthmatic airways is dependent on CC chemokine receptor 4 Source: Eur Respir J 2006; 28: Suppl. 50, 300s Year: 2006
Differential expression and regulation of toll-like receptors 1-9 in human airway epithelial cells Source: Eur Respir J 2001; 18: Suppl. 33, 19s Year: 2001
ILC2 cells from severe allergic and eosinophilic asthma demonstrate increased expression of TSLP receptor (TSLPR) and enhanced proliferative capacity. Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021
Toll-like receptors in human T lymphocytes: altered expression during tonsillar inflammation Source: Eur Respir J 2005; 26: Suppl. 49, 223s Year: 2005
A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation Source: Eur Respir J 2008; 31: 783-789 Year: 2008
Upregulation of CD4+ and CD8+ cells expressing CX3CR1 in asthmatics Source: Annual Congress 2006 - Towards understanding the pathogenesis of asthma Year: 2006
The pro-apoptotic effect of cysteinyl leukotriene receptor (CysLT-R) antagonist montelukast is mediated by CysLT-Rs expression on antigen-stimulated T cells Source: Eur Respir J 2003; 22: Suppl. 45, 100s Year: 2003
The CCR7 ligand CCL19 (MIP-3β) is expressed by mast cells Source: Annual Congress 2004 - Inflammation and remodelling in human lungs Year: 2004
Increase of both blood CXCR3+ and CCR4+ helper T cells associated with severity of asthma Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma Year: 2005
Allergen immunotherapy downregulate CD86 expression on dendritic cells and upregulate CTLA-4 expression on T cells in a mouse asthma model Source: Eur Respir J 2005; 26: Suppl. 49, 135s Year: 2005
Protease activated receptor 2 (PAR2) antagonism reduces pro-inflammatory cytokine production in bronchial epithelial cells Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020
The up-regulation of cysteinyl-leukotriene receptors on T cells Source: Eur Respir J 2003; 22: Suppl. 45, 395s Year: 2003
High-level expression of PD-L2 molecules by dendritic cells suppressed the Th2 response in allergic mouse Source: Eur Respir J 2007; 30: Suppl. 51, 368s Year: 2007
Attenuated cytokine response and enhanced toll-like receptor expression by budesonide in bronchial epithelial cells Source: Eur Respir J 2006; 28: Suppl. 50, 101s Year: 2006